Urinary N-telopeptide is a rapid predictor of response to and palliative benefit from bisphosphonate therapy in patients with metastatic breast cancer.
Support Cancer Ther
; 4(4): 182-7, 2007 Sep 01.
Article
em En
| MEDLINE
| ID: mdl-18632515
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article